Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Cirrhosis

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 103 articles:
HTML format
Text format



Single Articles


    May 2019
  1. EDDOWES PJ, Sasso M, Allison M, Tsochatzis E, et al
    Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2019;156:1717-1730.
    PubMed     Text format     Abstract available


    April 2019
  2. KIM HP, Moon AM, Dellon ES
    Noninvasively Predicting Hemodynamic Response to Carvedilol in Cirrhotic Patients with Varices: You Have Some Ex-Spleening to Do.
    Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36721.
    PubMed     Text format    


  3. O'LEARY JG, Greenberg CS, Patton HM, Caldwell SH, et al
    Coagulation in Cirrhosis.
    Gastroenterology. 2019 Apr 12. pii: S0016-5085(19)35694.
    PubMed     Text format    


  4. CASTERA L, Friedrich-Rust M, Loomba R
    Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2019;156:1264-1281.
    PubMed     Text format     Abstract available


    March 2019
  5. FERNANDEZ J, Claria J, Amoros A, Aguilar F, et al
    Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.
    Gastroenterology. 2019 Mar 21. pii: S0016-5085(19)33576.
    PubMed     Text format     Abstract available


  6. LOMBARDI A, Mondelli MU, Bruno R
    RE: Effects of long-term norfloxacin therapy in patients with advanced cirrhosis.
    Gastroenterology. 2019 Mar 14. pii: S0016-5085(19)33560.
    PubMed     Text format    


  7. ARROYO V
    Acute-On-Chronic Liver Failure in Cirrhosis Requires Expedited Decision for Liver Transplantation.
    Gastroenterology. 2019 Mar 5. pii: S0016-5085(19)32514.
    PubMed     Text format    


  8. MOON AM, Weiss NS, Beste LA, Su F, et al
    Reply.
    Gastroenterology. 2019;156:1218-1220.
    PubMed     Text format    


    February 2019
  9. DE FRANCHIS R
    The Changing Scenario of Screening and Surveillance of Esophageal Varices.
    Gastroenterology. 2019 Feb 15. pii: S0016-5085(19)30384.
    PubMed     Text format    


  10. INTAGLIATA NM, Caldwell SH, Tripodi A
    Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.
    Gastroenterology. 2019 Feb 13. pii: S0016-5085(19)30372.
    PubMed     Text format     Abstract available


  11. THABUT D, Bureau C, Layese R, Bourcier V, et al
    Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients with Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Gastroenterology. 2019 Feb 12. pii: S0016-5085(18)35303.
    PubMed     Text format     Abstract available


  12. ANDERSON RT, Lim SG, Mishra P, Josephson F, et al
    Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus.
    Gastroenterology. 2019;156:529-533.
    PubMed     Text format    


    January 2019
  13. MOSSANEN JC, Kohlhepp M, Wehr A, Krenkel O, et al
    CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T and CD4+ T cell-Dependent Control of Senescence.
    Gastroenterology. 2019 Jan 30. pii: S0016-5085(19)30342.
    PubMed     Text format     Abstract available


  14. GRINDHEIM JM, Nicetto D, Donahue G, Zaret KS, et al
    PRC2 proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Gene Expression at Promoter Regions in Euchromatin in Mice.
    Gastroenterology. 2019 Jan 25. pii: S0016-5085(19)30104.
    PubMed     Text format     Abstract available


  15. BAJAJ JS, Fagan A, Gavis EA, Kassam Z, et al
    Long-term Outcomes after Fecal Microbiota Transplant in Cirrhosis.
    Gastroenterology. 2019 Jan 18. pii: S0016-5085(19)30093.
    PubMed     Text format    


  16. KAPLAN DE, Serper M, Mehta R, Fox R, et al
    Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30053.
    PubMed     Text format     Abstract available


  17. LAI JC, Rahimi R, Verna EC, Kappus MR, et al
    Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multi-Center Study.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30058.
    PubMed     Text format     Abstract available


  18. CHATURANTABUT S, Shwartz A, Evason KJ, Cox AG, et al
    Estrogen Activation of G protein-coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes.
    Gastroenterology. 2019 Jan 11. pii: S0016-5085(19)30031.
    PubMed     Text format     Abstract available


  19. KO S, Russell JO, Tian J, Gao C, et al
    Hdac1 Regulates Differentiation of Bipotent Liver Progenitor Cells During Regeneration via Sox9b and Cdk8.
    Gastroenterology. 2019;156:187-202.
    PubMed     Text format     Abstract available


    December 2018
  20. PIANO S, Singh V, Caraceni P, Maiwall R, et al
    Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.
    Gastroenterology. 2018 Dec 12. pii: S0016-5085(18)35402.
    PubMed     Text format     Abstract available


  21. MAJEED A, Roberts SK, Kemp W
    RE: No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients with Cirrhosis.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35391.
    PubMed     Text format    


  22. LIDOFSKY SD
    Screening For Hepatocellular Carcinoma In Cirrhosis: Challenges And Unresolved Issues.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35390.
    PubMed     Text format    


  23. SINGAL AG, Murphy CC
    Hepatocellular Carcinoma Surveillance: An effective but complex process.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35393.
    PubMed     Text format    


  24. MEHTA N, Monto A, Yao FY
    Screening for hepatocellular carcinoma to improve cancer-related mortality: Looking behind when we should be looking ahead.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35392.
    PubMed     Text format    


    November 2018
  25. ELSSNER C, Goeppert B, Longerich T, Scherr AL, et al
    Nuclear Translocation of RELB is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35260.
    PubMed     Text format     Abstract available


    October 2018
  26. IOANNOU GN, Feld JJ
    What are the Benefits of a Sustained Virologic Response to Direct-acting Antiviral Therapy for HCV Infection?
    Gastroenterology. 2018 Oct 24. pii: S0016-5085(18)35166.
    PubMed     Text format     Abstract available


  27. KOH C, Heller T, Glenn JS
    Pathogenesis of and New Therapies for Hepatitis D.
    Gastroenterology. 2018 Oct 18. pii: S0016-5085(18)35162.
    PubMed     Text format     Abstract available


  28. BRAILLON A
    Hepatocellular carcinoma screening: seeking robust evidence ....
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35148.
    PubMed     Text format    


  29. MONTANO-LOZA AJ, Hansen BE, Corpechot C, Roccarina D, et al
    Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.
    Gastroenterology. 2018 Oct 5. pii: S0016-5085(18)35089.
    PubMed     Text format     Abstract available


  30. PERRY I, Patel D
    Hemoptysis: Call the Gastroenterologist?
    Gastroenterology. 2018;155:e1-e2.
    PubMed     Text format    


    September 2018
  31. ZHAI ZZ, Wang L, Zuo XL
    A Rare Cause of Gastrointestinal Bleeding in a Patient With a History of Alcoholic Cirrhosis.
    Gastroenterology. 2018 Sep 18. pii: S0016-5085(18)35021.
    PubMed     Text format    


  32. ZHANG XP, Wang K, Cheng SQ
    Surveillance for Early-Stage Hepatocellular Carcinoma by Ultrasound Plus Alpha-Fetoprotein Measurement: More Details, More Significance.
    Gastroenterology. 2018 Sep 15. pii: S0016-5085(18)34774.
    PubMed     Text format    


  33. LOOMBA R, Sanyal AJ, Kowdley KV, Terrault N, et al
    Factors Associated with Histologic Response in Adult Patients with Nonalcoholic Steatohepatitis.
    Gastroenterology. 2018 Sep 14. pii: S0016-5085(18)34977.
    PubMed     Text format     Abstract available


  34. LUO X, Li H, Ma L, Zhou J, et al
    Expression of STING Is Increased in Liver Tissues from Patients With NAFLD and Promotes Macrophage-mediated Hepatic Inflammation and Fibrosis in Mice.
    Gastroenterology. 2018 Sep 10. pii: S0016-5085(18)34959.
    PubMed     Text format     Abstract available


  35. COOPER GS
    Should We Abandon Current Hepatocellular Carcinoma Screening Practices?
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34934.
    PubMed     Text format    


  36. JACOBSON IM
    Re: Sofosbuvir, Velpatasvir, and Ribavirin in HCV.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34936.
    PubMed     Text format    


    August 2018
  37. MOREAU R, Elkrief L, Bureau C, Perarnau JM, et al
    Effects of Long-term Norfloxacin Therapy in Patients with Advanced Cirrhosis.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34891.
    PubMed     Text format     Abstract available


  38. KANWAL F, Kramer JR, Mapakshi S, Natarajan Y, et al
    Risk of Hepatocellular Cancer in Patients with Non-alcoholic Fatty Liver Disease.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34889.
    PubMed     Text format     Abstract available


  39. KLEBER G, Sauerbruch T
    Concomitant gastric varices: Bleeding risk sign in patients with liver cirrhosis and esophageal varices?
    Gastroenterology. 2018 Aug 21. pii: S0016-5085(18)34879.
    PubMed     Text format    


  40. THEVENOT T, Weil D, Di Martino V
    What is the true relationship between spontaneous portosystemic shunts and portopulmonary hypertension in cirrhotic patients?
    Gastroenterology. 2018 Aug 14. pii: S0016-5085(18)34878.
    PubMed     Text format    


  41. SCHREINER P, Puippe G, Gubler C
    An Unusual, But Potentially Life-Threatening Lesion in the Cecum.
    Gastroenterology. 2018;155:e9-e10.
    PubMed     Text format    


  42. VILAR-GOMEZ E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, et al
    Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Gastroenterology. 2018;155:443-457.
    PubMed     Text format     Abstract available


  43. AJMERA V, Park CC, Caussy C, Singh S, et al
    Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018;155:307-310.
    PubMed     Text format     Abstract available


    July 2018
  44. LOOMBA R, Kayali Z, Noureddin M, Ruane P, et al
    GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients with Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018 Jul 27. pii: S0016-5085(18)34815.
    PubMed     Text format     Abstract available


  45. TRIPATHI DM, Vilaseca M, Lafoz E, Garcia-Caldero H, et al
    Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Gastroenterology. 2018 Jul 25. pii: S0016-5085(18)34810.
    PubMed     Text format     Abstract available


  46. NAHON P, Layese R, Bourcier V, Cagnot C, et al
    Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
    Gastroenterology. 2018 Jul 18. pii: S0016-5085(18)34781.
    PubMed     Text format     Abstract available


  47. HARRISON SA, Abdelmalek MF, Caldwell S, Shiffman ML, et al
    Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.
    Gastroenterology. 2018 Jul 7. pii: S0016-5085(18)34758.
    PubMed     Text format     Abstract available


  48. MOON AM, Weiss NS, Beste LA, Su F, et al
    No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-related Mortality in Patients with Cirrhosis.
    Gastroenterology. 2018 Jul 5. pii: S0016-5085(18)34721.
    PubMed     Text format     Abstract available


  49. ASHHAB AA, Singh D, Debes JD
    A Rare Cause of a Left Abdominal Liver Mass.
    Gastroenterology. 2018;155:e12-e13.
    PubMed     Text format    


    June 2018
  50. ESTEBAN R, Pineda JA, Calleja JL, Casado M, et al
    Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With HCV genotype 3 Infection and Cirrhosis.
    Gastroenterology. 2018 Jun 26. pii: S0016-5085(18)34684.
    PubMed     Text format     Abstract available


    May 2018
  51. GARDINI AC, Conti F, Brillanti S, Andreone P, et al
    Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals.
    Gastroenterology. 2018 May 7. pii: S0016-5085(18)30419.
    PubMed     Text format    


  52. COSTENTIN C, Layese R, Bourcier V, Cagnot C, et al
    Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-time Adjusted Survival of Patients With Compensated Viral Cirrhosis.
    Gastroenterology. 2018 May 2. pii: S0016-5085(18)30488.
    PubMed     Text format     Abstract available


    April 2018
  53. CALVARUSO V, Cabibbo G, Cacciola I, Petta S, et al
    Incidence of Hepatocellular Carcinoma in Patients with HCV-associated Cirrhosis Treated with Direct-Acting Antiviral Agents.
    Gastroenterology. 2018 Apr 12. pii: S0016-5085(18)30441.
    PubMed     Text format     Abstract available


  54. THIELE M, Madsen BS, Hansen JF, Detlefsen S, et al
    Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.
    Gastroenterology. 2018;154:1369-1379.
    PubMed     Text format     Abstract available


    March 2018
  55. EL-SHERIF O, Jiang ZG, Tapper EB, Huang KC, et al
    Baseline Factors Associated with Improvements in Decompensated Cirrhosis After Direct-acting Antiviral Therapy for HCV Infection.
    Gastroenterology. 2018 Mar 10. pii: S0016-5085(18)30314.
    PubMed     Text format     Abstract available


  56. LO GH
    The Elevation of Hepatic Venous Pressure Gradient After Sustained Virologic Response in Hepatitis C Virus-Related Cirrhosis.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30148.
    PubMed     Text format    


  57. PONZETTO A, Figura N
    Risk of Hepatocellular Carcinoma After Cure of Hepatitis C Virus.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30153.
    PubMed     Text format    


  58. HARVEY LD, Chan SY
    YAPping About Glutaminolysis in Hepatic Fibrosis.
    Gastroenterology. 2018 Mar 3. pii: S0016-5085(18)30259.
    PubMed     Text format    


    February 2018
  59. TEDESCO D, Thapa M, Chin CY, Ge Y, et al
    Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic gammadelta T-cell Receptor-positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30214.
    PubMed     Text format     Abstract available


  60. DOU C, Liu Z, Tu K, Zhang H, et al
    P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-promoting Myofibroblasts.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30209.
    PubMed     Text format     Abstract available


  61. TZARTZEVA K, Obi J, Rich NE, Parikh ND, et al
    Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30155.
    PubMed     Text format     Abstract available


    January 2018
  62. SIMON-TALERO M, Roccarina D, Martinez J, Lampichler K, et al
    Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Gastroenterology. 2018 Jan 20. pii: S0016-5085(18)30069.
    PubMed     Text format     Abstract available


  63. MANCUSO A, Politi F, Maringhini A
    Portal Vein Thromboses in Cirrhosis: To Treat or Not to Treat?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36673.
    PubMed     Text format    


  64. WOOD CP, Rowe IA
    What Are the Benefits of Anticoagulation for Portal Vein Thrombosis in Individuals With Cirrhosis?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36671.
    PubMed     Text format    


  65. CHEN H, Lv Y, Han G
    Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: Not Only Recanalize the Portal Vein.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36672.
    PubMed     Text format    


  66. QI X, Valla DC, Guo X
    Anticoagulation for Portal Vein Thrombosis in Cirrhosis: Selection of Appropriate Patients.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36669.
    PubMed     Text format    


  67. DU K, Hyun J, Premont RT, Choi SS, et al
    Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Hepatic Stellate Cell Activation.
    Gastroenterology. 2018 Jan 3. pii: S0016-5085(18)30002.
    PubMed     Text format     Abstract available


    November 2017
  68. SHERMAN KE, Shah VH
    Viral Hepatitis: Knowledge and Treatments for HBV/HCV and Associated Transplantation and Neoplasia.
    Gastroenterology. 2017 Nov 14. pii: S0016-5085(17)36348.
    PubMed     Text format    


    October 2017
  69. JOHN M, Metwally M, Mangia A, Romero-Gomez M, et al
    TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C.
    Gastroenterology. 2017 Oct 6. pii: S0016-5085(17)36134.
    PubMed     Text format    


    July 2017
  70. LENS S, Alvarado E, Marino Z, Londono MC, et al
    Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.
    Gastroenterology. 2017 Jul 19. pii: S0016-5085(17)35922.
    PubMed     Text format     Abstract available


  71. KING A, Houlihan DD, Kavanagh D, Haldar D, et al
    Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.
    Gastroenterology. 2017;153:233-248.
    PubMed     Text format     Abstract available


  72. KHAMRI W, Abeles RD, Hou TZ, Anderson AE, et al
    Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.
    Gastroenterology. 2017;153:263-276.
    PubMed     Text format     Abstract available


    June 2017
  73. KANWAL F, Kramer J, Asch SM, Chayanupatkul M, et al
    Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35797.
    PubMed     Text format     Abstract available


  74. CANNON MD, Heneghan MA
    Endoscopy in Pregnant Women with Liver Cirrhosis.
    Gastroenterology. 2017 Jun 1. pii: S0016-5085(17)35602.
    PubMed     Text format    


    May 2017
  75. LOFFREDO L, Pastori D, Farcomeni A, Violi F, et al
    Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: a Systematic Review and Meta-Analysis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35552.
    PubMed     Text format     Abstract available


  76. KHAN MA, Cholankeril G, Howden CW
    Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding?
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35404.
    PubMed     Text format    


  77. ASSARAF J, Weiss N, Thabut D
    Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood-Brain Barrier Drug Transport.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35403.
    PubMed     Text format    


  78. SINGH S, Muir AJ, Dieterich DT, Falck-Ytter YT, et al
    American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Gastroenterology. 2017;152:1544-1577.
    PubMed     Text format     Abstract available


  79. LAI KKY, Kweon SM, Chi F, Hwang E, et al
    Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
    Gastroenterology. 2017;152:1477-1491.
    PubMed     Text format     Abstract available


    April 2017
  80. AN SY, Jang YJ, Lim HJ, Han J, et al
    Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.
    Gastroenterology. 2017;152:1174-1186.
    PubMed     Text format     Abstract available


    March 2017
  81. JACOBSON IM, Lim JK, Fried MW
    AGA Institute Clinical Practice Update: Care of Patients Who Have Achieved a Sustained Virologic Response (SVR) Following Antiviral Therapy for Chronic Hepatitis C Infection.
    Gastroenterology. 2017 Mar 23. pii: S0016-5085(17)30327.
    PubMed     Text format     Abstract available


  82. MANCUSO A
    Classification of Portal Vein Thrombosis in Cirrhosis.
    Gastroenterology. 2017 Mar 3. pii: S0016-5085(17)30135.
    PubMed     Text format    


    February 2017
  83. JACOBSON IM, Lawitz E, Kwo PY, Hezode C, et al
    Safety and Efficacy of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Infection and Compensated Cirrhosis: an Integrated Analysis.
    Gastroenterology. 2017 Feb 10. pii: S0016-5085(17)30150.
    PubMed     Text format     Abstract available


  84. MATSUURA K, Sawai H, Ikeo K, Ogawa S, et al
    Genome-wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Gastroenterology. 2017 Feb 2. pii: S0016-5085(17)30130.
    PubMed     Text format     Abstract available


  85. RAVI S, Axley P, Jones D, Kodali S, et al
    Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Gastroenterology. 2017 Feb 1. pii: S0016-5085(16)35535.
    PubMed     Text format    


  86. PARK CC, Nguyen P, Hernandez C, Bettencourt R, et al
    Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2017;152:598-607.
    PubMed     Text format     Abstract available


    January 2017
  87. GOLDBERG D, Ditah IC, Saeian K, Lalehzari M, et al
    Changes in the Prevalence of Hepatitis C Virus Infection, Non-alcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients with Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Gastroenterology. 2017 Jan 11. pii: S0016-5085(17)30014.
    PubMed     Text format     Abstract available


    November 2016
  88. SINGAL AG, Tiro JA, Marrero JA, McCallister K, et al
    Mailed Outreach Program Increases Ultrasound Screening of Patients with Cirrhosis for Hepatocellular Carcinoma.
    Gastroenterology. 2016 Nov 5. pii: S0016-5085(16)35321.
    PubMed     Text format     Abstract available


    October 2016
  89. WEERSINK RA, Drenth JP, Borgsteede SD
    Altered Pharmacokinetics of Statins Explain Increased Risk of Rhabdomyolysis in Advanced Cirrhosis.
    Gastroenterology. 2016 Oct 3. pii: S0016-5085(16)35074.
    PubMed     Text format    


  90. LO GH
    Did Statins Really Improve Survival in Cirrhotic Patients With a History of Variceal Bleeding?
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35075.
    PubMed     Text format    


    September 2016
  91. BUREAU C, Thabut D, Oberti F, Dharancy S, et al
    Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Gastroenterology. 2016 Sep 20. pii: S0016-5085(16)35110.
    PubMed     Text format     Abstract available


  92. NAHON P, Bourcier V, Layese R, Audureau E, et al
    Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
    Gastroenterology. 2016 Sep 15. pii: S0016-5085(16)35070.
    PubMed     Text format     Abstract available


  93. TSAI CF, Chen MH, Wang YP, Chu CJ, et al
    Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in Population Study.
    Gastroenterology. 2016 Sep 14. pii: S0016-5085(16)35032.
    PubMed     Text format     Abstract available


    August 2016
  94. TERRAULT NA, Zeuzem S, Di Bisceglie AM, Lim JK, et al
    Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated of Sustained Virologic Response.
    Gastroenterology. 2016 Aug 23. pii: S0016-5085(16)34927.
    PubMed     Text format     Abstract available


    June 2016
  95. IOANNOU GN, Beste LA, Chang MF, Green PK, et al
    Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Healthcare System.
    Gastroenterology. 2016 Jun 4. pii: S0016-5085(16)34575.
    PubMed     Text format     Abstract available


    May 2016
  96. GANE EJ, Schwabe C, Hyland RH, Yang Y, et al
    Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-naive or Previously Treated Patients with HCV Genotype 1 or 3 Infections.
    Gastroenterology. 2016 May 27. pii: S0016-5085(16)34513.
    PubMed     Text format     Abstract available


  97. MANCINA RM, Dongiovanni P, Petta S, Pingitore P, et al
    The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
    Gastroenterology. 2016;150:1219-1230.
    PubMed     Text format     Abstract available


    April 2016
  98. GINES P
    Management of Hepatorenal Syndrome in the Era of Acute-on-Chronic Liver Failure: Telipressin and Beyond.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)34324.
    PubMed     Text format    


  99. BARRESI L, Ligresti D, Traina M
    A Challenging Diagnosis for a Biliary Stricture.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00215.
    PubMed     Text format    


    March 2016
  100. ROCKEY DC
    A new treatment for portal hypertension?
    Gastroenterology. 2016 Mar 23. pii: S0016-5085(16)00368.
    PubMed     Text format    


  101. LASSAILLY G, Caiazzo R, Pattou F, Mathurin P, et al
    Perspectives on Treatment for Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Mar 10. pii: S0016-5085(16)00323.
    PubMed     Text format     Abstract available


    February 2016
  102. RATZIU V, Harrison S, Francque S, Bedossa P, et al
    Elafibranor, an Agonist of the Peroxisome Proliferator-activated Receptor-alpha and -delta, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
    Gastroenterology. 2016 Feb 10. pii: S0016-5085(16)00140.
    PubMed     Text format     Abstract available


  103. SERFATY L
    Clinical implications of concomitant alcohol use, obesity and viral hepatitis.
    Gastroenterology. 2016 Feb 9. pii: S0016-5085(16)00139.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: